MOH
- Marketing authorisation holder: CHECKPOINT THERAPEUTICS INC
- Status: likely_approved
🇮🇱 Unloxcyt in Israel
Unloxcyt (COSIBELIMAB) regulatory status in Israel.
Marketing authorisation
Unloxcyt in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Unloxcyt approved in Israel?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Unloxcyt in Israel?
CHECKPOINT THERAPEUTICS INC holds the Israeli marketing authorisation.